HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jamshid Gholizadeh Navashenaq Selected Research

Adenosine (Adenocard)

1/2022Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jamshid Gholizadeh Navashenaq Research Topics

Disease

9Neoplasms (Cancer)
10/2022 - 01/2021
7Inflammation (Inflammations)
10/2022 - 10/2019
3Infections
10/2022 - 10/2019
3Rheumatoid Arthritis
06/2022 - 01/2022
2Ankylosing Spondylitis
06/2022 - 04/2021
2Psoriasis (Pustulosis Palmaris et Plantaris)
06/2022 - 01/2022
2Sepsis (Septicemia)
10/2021 - 10/2019
1Colorectal Neoplasms (Colorectal Cancer)
10/2022
1Behcet Syndrome (Behcet's Syndrome)
06/2022
1Chronic Disease (Chronic Diseases)
06/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2022
1Rheumatic Diseases (Rheumatism)
06/2022
1Systemic Scleroderma (Systemic Sclerosis)
06/2022
1Multiple Sclerosis
01/2022
1Hypersensitivity (Allergy)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2021
1COVID-19
10/2021
1Malnutrition (Nutritional Deficiencies)
09/2021
1Critical Illness (Critically Ill)
09/2021
1Traumatic Brain Injuries (Traumatic Brain Injury)
09/2021
1Fibrosis (Cirrhosis)
03/2021
1Non-alcoholic Fatty Liver Disease
03/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021

Drug/Important Bio-Agent (IBA)

7CytokinesIBA
06/2022 - 01/2021
5ChemokinesIBA
10/2022 - 01/2021
5Propolis (Bee Bread)IBA
04/2022 - 10/2019
2pycnogenolsIBA
06/2022 - 09/2021
2AntioxidantsIBA
06/2022 - 04/2022
2Interleukin-17 (Interleukin 17)IBA
04/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
2MelatoninIBA
01/2022 - 10/2019
1MicroRNAs (MicroRNA)IBA
10/2022
1Insulin ReceptorIBA
06/2022
1Free RadicalsIBA
06/2022
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
06/2022
1Serine (L-Serine)FDA Link
06/2022
1Insulin Receptor Substrate ProteinsIBA
06/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022
1LipidsIBA
04/2022
1NF-kappa B (NF-kB)IBA
04/2022
1Malondialdehyde (Propanedial)IBA
04/2022
1Small Interfering RNA (siRNA)IBA
01/2022
1VaccinesIBA
01/2022
1Immune Checkpoint ProteinsIBA
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
01/2022
1Adenosine (Adenocard)FDA LinkGeneric
01/2022
1Apoptosis Regulatory ProteinsIBA
01/2022
1B7-H1 AntigenIBA
11/2021
1Therapeutic UsesIBA
11/2021
1Monoclonal AntibodiesIBA
11/2021
1Immune Checkpoint InhibitorsIBA
11/2021
1Immunoglobulins (Immunoglobulin)IBA
10/2021
1OligopinIBA
09/2021
1AminopeptidasesIBA
04/2021
1C-Reactive ProteinIBA
03/2021
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
03/2021
1CurcuminIBA
01/2021
1CateninsIBA
01/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2021
1AntibodiesIBA
01/2021
1MidkineIBA
01/2021
1Chemokine CXCL16IBA
01/2021
1Pharmaceutical PreparationsIBA
10/2019

Therapy/Procedure

5Therapeutics
01/2022 - 01/2021
3Immunotherapy
01/2022 - 08/2021
1Diet Therapy (Therapy, Diet)
06/2022
1Ligation
01/2022